会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • SYSTEM FOR DEVELOPMENT OF INDIVIDUALISED TREATMENT REGIMENS
    • 发展个体化治疗方案制度
    • WO2006113987A1
    • 2006-11-02
    • PCT/CA2006/000653
    • 2006-04-25
    • CADUCEUS INFORMATION SYSTEMS INC.DRANITSARIS, GeorgeVINCENT, Mark
    • DRANITSARIS, GeorgeVINCENT, Mark
    • A61B5/00G06F19/00
    • G16H50/70G06F19/00G16H10/20G16H50/20G16H50/30G16H50/50
    • A system is provided for facilitating the development of an individualised treatment regimen for a patient based on an evaluation of the risk(s) associated with a disease and/or associated with known treatment options. In order to evaluate these risk(s), the system utilises clinical data from a plurality of patients having the disease in question. The clinical data includes information for each of the plurality of patients relating to the presence, absence and/or severity of one or more negative events. The negative event(s) can be disease-related, for example, a complication such as metastasis of a cancer to bone or the brain, or the negative event(s) can be treatment-related, for example a toxicity associated with the treatment. The system can also include prediction models that allow the probability that a patient will develop a toxicity or complication to be assessed. Methods for developing prediction models are provided.
    • 提供了一种系统,用于基于与疾病相关的风险的评估和/或与已知治疗选择相关联的方式促进针对患者的个体化治疗方案的开发。 为了评估这些风险,该系统利用来自患有该疾病的多个患者的临床数据。 临床数据包括与一个或多个阴性事件的存在,不存在和/或严重性相关的多个患者中的每一个的信息。 阴性事件可以是疾病相关的,例如,诸如癌症对骨或脑的转移的并发症,或者阴性事件可以是治疗相关的,例如与治疗相关的毒性 。 该系统还可以包括允许患者发生毒性或并发症评估的可能性的预测模型。 提供了开发预测模型的方法。
    • 7. 发明申请
    • USE OF N,N-DIETHYL-2-[-4-(PHENYLMETHYL)-PHENOXY]ETHANAMINE MONOHYDROCHLORIDE (DPPE) IN CANCER THERAPY
    • N,N-二乙基-2 - [ - 4-(苯基甲基) - 苯氧基]乙酰胺单盐酸盐(DPPE)在癌症治疗中的应用
    • WO2003037318A1
    • 2003-05-08
    • PCT/CA2002/001651
    • 2002-11-01
    • VINCENT, Mark
    • VINCENT, Mark
    • A61K31/138
    • A61K31/704A61K31/138A61K2300/00
    • The present invention provides for the use of N,N-diethyl-2-[-4-(phenylmethyl)-phenoxy]ethanamine monohydrochloride (DPPE) in cancer therapy. DPPE is used in the treatment of patients having, or suspected of having, an aggressive cancer. The present invention further provides for the use of DPPE in the treatment of a patient suspected of having an existing cancer, wherein the use follows a surgery for treatment of a primary cancer that is estrogen-receptor negative. Also provided are pharmaceutical compositions comprising DPPE for use in the treatment of patients having, or suspected of having, an aggressive cancer and pharmaceutical kits comprising such compositions.
    • 本发明提供N,N-二乙基-2- [ - 4-(苯基甲基) - 苯氧基]乙胺单盐酸盐(DPPE)在癌症治疗中的用途。 DPPE用于治疗患有或怀疑患有侵袭性癌症的患者。 本发明进一步提供DPPE用于治疗疑似患有现有癌症的患者,其中所述用途遵循用于治疗雌激素受体阴性的原发性癌症的手术。 还提供了包含DPPE的药物组合物,其用于治疗患有侵袭性癌症的患者或怀疑具有侵袭性癌症的患者以及包含该组合物的药物试剂盒。